{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T20:22:06Z","timestamp":1789590126219,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012899","name":"Lanzhou University","doi-asserted-by":"publisher","award":["20260260003"],"award-info":[{"award-number":["20260260003"]}],"id":[{"id":"10.13039\/100012899","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012899","name":"Lanzhou University","doi-asserted-by":"publisher","award":["20260260018"],"award-info":[{"award-number":["20260260018"]}],"id":[{"id":"10.13039\/100012899","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007764","name":"Lanzhou Science and Technology Bureau","doi-asserted-by":"publisher","award":["2025-2-100"],"award-info":[{"award-number":["2025-2-100"]}],"id":[{"id":"10.13039\/501100007764","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007764","name":"Lanzhou Science and Technology Bureau","doi-asserted-by":"publisher","award":["2024-4-2"],"award-info":[{"award-number":["2024-4-2"]}],"id":[{"id":"10.13039\/501100007764","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007764","name":"Lanzhou Science and Technology Bureau","doi-asserted-by":"publisher","award":["2025-2-103"],"award-info":[{"award-number":["2025-2-103"]}],"id":[{"id":"10.13039\/501100007764","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bcp.2026.118133","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T16:09:45Z","timestamp":1780502985000},"page":"118133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"P1","title":["Targeting CDK4 with repurposing perphenazine inhibited the growth of gastric cancer AGS and HGC27 cells by arresting cell cycle"],"prefix":"10.1016","volume":"251","author":[{"given":"Yunhao","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongkun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanchun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baizhuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanxiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingqian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2026.118133_b0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21114012","article-title":"Gastric Cancer: Epidemiology, Risk Factors, Classification, Genomic Characteristics and Treatment strategies","volume":"21","author":"Machlowska","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.118133_b0010","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.2147\/JIR.S383191","article-title":"PLXDC1 can Be a Biomarker for Poor Prognosis and Immune Evasion in Gastric Cancer","volume":"15","author":"Li","year":"2022","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.bcp.2026.118133_b0015","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13045-023-01451-3","article-title":"Gastric cancer treatment: recent progress and future perspectives","volume":"16","author":"Guan","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bcp.2026.118133_b0020","doi-asserted-by":"crossref","first-page":"12931","DOI":"10.1080\/21655979.2021.2012620","article-title":"Long non-coding RNA CERS6-AS1 plays a prognostic role in promoting the progression of gastric cancer","volume":"12","author":"Li","year":"2021","journal-title":"Bioengineered"},{"key":"10.1016\/j.bcp.2026.118133_b0025","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","article-title":"Gastric cancer","volume":"396","author":"Smyth","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2026.118133_b0030","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41571-023-00747-0","article-title":"Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention","volume":"20","author":"Thrift","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bcp.2026.118133_b0035","first-page":"264","article-title":"Current treatment and recent progress in gastric cancer","volume":"71","author":"Joshi","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bcp.2026.118133_b0040","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s10555-020-09925-3","article-title":"Gastric cancer: a comprehensive review of current and future treatment strategies","volume":"39","author":"Sexton","year":"2020","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bcp.2026.118133_b0045","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2174\/0115665232332419250213081510","article-title":"Targeting of Ykl-40 as a Protumor in Personalized Medicine: a New Dimension in Disease Understanding","volume":"26","author":"Moustafa","year":"2025","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.bcp.2026.118133_b0050","doi-asserted-by":"crossref","unstructured":"Liu, P., N. Li, J. Guo, G.T. Zhao, J. Wang, Z. Mou, et al., Immune checkpoint inhibitor therapy for gastric cancer: current status, therapeutic challenges, and future prospects, Volume 17 - 2026 (2026).","DOI":"10.3389\/fimmu.2026.1716934"},{"key":"10.1016\/j.bcp.2026.118133_b0055","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.3892\/or.2015.4528","article-title":"Targeted therapy for gastric cancer: current status and future directions (Review)","volume":"35","author":"Yuan","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bcp.2026.118133_b0060","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317714626","article-title":"Progress in the treatment of advanced gastric cancer","volume":"39","author":"Song","year":"2017","journal-title":"Tumour Biol."},{"key":"10.1016\/j.bcp.2026.118133_b0065","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41392-021-00572-w","article-title":"Small molecules in targeted cancer therapy: advances, challenges, and future perspectives","volume":"6","author":"Zhong","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bcp.2026.118133_b0070","first-page":"1465","article-title":"DNA repair proteins as the targets for paroxetine to induce cytotoxicity in gastric cancer cell AGS","volume":"12","author":"Liu","year":"2022","journal-title":"Am. J. Cancer Res."},{"issue":"2022","key":"10.1016\/j.bcp.2026.118133_b0075","first-page":"e181","article-title":"Small molecule inhibitors targeting the cancers","volume":"3","author":"Liu","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/j.bcp.2026.118133_b0080","first-page":"8643","article-title":"and E","volume":"68","author":"DeVita","year":"2008","journal-title":"Chu, A History of Cancer Chemotherapy, Cancer Res."},{"key":"10.1016\/j.bcp.2026.118133_b0085","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.drudis.2020.07.024","article-title":"High-Throughput Screening: today\u2019s biochemical and cell-based approaches","volume":"25","author":"Blay","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bcp.2026.118133_b0090","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.apsb.2012.10.004","article-title":"Preclinical experimental models of drug metabolism and disposition in drug discovery and development","volume":"2","author":"Zhang","year":"2012","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bcp.2026.118133_b0095","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.semcancer.2019.12.012","article-title":"Drug repurposing for cancer therapy, easier said than done","volume":"68","author":"Gonzalez-Fierro","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bcp.2026.118133_b0100","doi-asserted-by":"crossref","DOI":"10.2174\/0115701638253929230922115127","article-title":"Drug Repositioning: a Monetary Stratagem to Discover a New Application of drugs","volume":"21","author":"Rohilla","year":"2024","journal-title":"Curr. Drug Discov. Technol."},{"key":"10.1016\/j.bcp.2026.118133_b0105","doi-asserted-by":"crossref","first-page":"967","DOI":"10.2165\/00003495-199957060-00015","article-title":"Sildenafil","volume":"57","author":"Langtry","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.bcp.2026.118133_b0110","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s11427-013-4487-z","article-title":"A drug from poison: how the therapeutic effect of arsenic trioxide on acute promyelocytic leukemia was discovered","volume":"56","author":"Rao","year":"2013","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.bcp.2026.118133_b0115","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1182\/blood.V72.2.567.567","article-title":"Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia","volume":"72","author":"Huang","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2026.118133_b0120","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1182\/blood-2019-01-894980","article-title":"Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet","volume":"133","author":"Sanz","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2026.118133_b0125","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1053\/j.gastro.2016.08.040","article-title":"Expression of DRD2 is increased in Human Pancreatic Ductal Adenocarcinoma and Inhibitors Slow Tumor Growth in mice","volume":"151","author":"Jandaghi","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2026.118133_b0130","doi-asserted-by":"crossref","DOI":"10.3892\/ol.2020.12374","article-title":"Perphenazine exerts antitumor effects on HUT78 cells through Akt dephosphorylation by protein phosphatase2A","volume":"21","author":"Tsuji","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bcp.2026.118133_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127239","article-title":"Repurposing of antipsychotics perphenazine for the treatment of endometrial cancer","volume":"30","author":"Chen","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bcp.2026.118133_b0140","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s00210-019-01668-5","article-title":"Antimelanoma activity of perphenazine and prochlorperazine in human COLO829 and C32 cell lines","volume":"392","author":"Otr\u0119ba","year":"2019","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118133_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118513","article-title":"PI3K\/AKT\/mTOR signaling in gastric cancer: Epigenetics and beyond","volume":"262","author":"Fattahi","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.bcp.2026.118133_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2026.151524","article-title":"Red ginseng polysaccharide targets the PI3K\/AKT\/mTOR pathway to induce mitochondrial apoptosis in bladder cancer","volume":"357","author":"Ullah","year":"2026","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bcp.2026.118133_b0155","article-title":"The PI3K\/Akt\/mTOR signaling pathway in gastric cancer; from oncogenic variations to the possibilities for pharmacologic interventions","volume":"898","author":"Khorasani","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118133_b0160","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00428-014-1588-4","article-title":"The PI3K\/AKT\/mTOR pathway is activated in gastric cancer with potential prognostic and predictive significance","volume":"465","author":"Tapia","year":"2014","journal-title":"Virchows Arch."},{"key":"10.1016\/j.bcp.2026.118133_b0165","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.apsb.2021.09.007","article-title":"Targeting PFKL with penfluridol inhibits glycolysis and suppresses esophageal cancer tumorigenesis in an AMPK\/FOXO3a\/BIM-dependent manner","volume":"12","author":"Zheng","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bcp.2026.118133_b0170","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3827933","article-title":"Simvastatin in the Treatment of Colorectal Cancer: a Review","volume":"2022","author":"Zang","year":"2022","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.bcp.2026.118133_b0175","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bcp.2018.11.003","article-title":"Non-mitotic effect of albendazole triggers apoptosis of human leukemia cells via SIRT3\/ROS\/p38 MAPK\/TTP axis-mediated TNF-\u03b1 upregulation","volume":"162","author":"Wang","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118133_b0180","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11010-016-2927-3","article-title":"Albendazole inhibits HIF-1\u03b1-dependent glycolysis and VEGF expression in non-small cell lung cancer cells","volume":"428","author":"Zhou","year":"2017","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bcp.2026.118133_b0185","doi-asserted-by":"crossref","DOI":"10.3390\/ph14040372","article-title":"Screening of Benzimidazole-based Anthelmintics and their Enantiomers as Repurposed Drug Candidates in Cancer Therapy","volume":"14","author":"Florio","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.bcp.2026.118133_b0190","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/07357900802210752","article-title":"Inhibition of cell proliferation, vascular endothelial growth factor and tumor growth by albendazole","volume":"27","author":"Pourgholami","year":"2009","journal-title":"Cancer Invest."},{"key":"10.1016\/j.bcp.2026.118133_b0195","doi-asserted-by":"crossref","DOI":"10.3390\/toxins11120731","article-title":"The Cytotoxicity effect of Resveratrol: Cell Cycle arrest and Induced Apoptosis of Breast Cancer 4T1 Cells","volume":"11","author":"Wu","year":"2019","journal-title":"Toxins (basel)."},{"key":"10.1016\/j.bcp.2026.118133_b0200","article-title":"Alkaloids and Colon Cancer: Molecular Mechanisms and Therapeutic Implications for Cell Cycle arrest","volume":"27","author":"Khan","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bcp.2026.118133_b0205","doi-asserted-by":"crossref","DOI":"10.3390\/cells11091479","article-title":"Crosstalk of Autophagy and Apoptosis","volume":"11","author":"Sorice","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.bcp.2026.118133_b0210","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s12094-020-02422-7","article-title":"ADMA mediates gastric cancer cell migration and invasion via Wnt\/\u03b2-catenin signaling pathway","volume":"23","author":"Guo","year":"2021","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.bcp.2026.118133_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.jare.2026.02.044","article-title":"Identification of a novel EphB4 inhibitor, Sanguinarine, which attenuates \u03b2-catenin signaling to inhibit tumor proliferation and migration in lung cancer","author":"Ullah","year":"2026","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.bcp.2026.118133_b0220","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3892\/ol.2020.12374","article-title":"Perphenazine exerts antitumor effects on HUT78 cells through Akt dephosphorylation by protein phosphatase2A","volume":"21","author":"Tsuji","year":"2021","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bcp.2026.118133_b0225","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41419-024-06779-3","article-title":"Antipsychotics possess anti-glioblastoma activity by disrupting lysosomal function and inhibiting oncogenic signaling by stabilizing PTEN","volume":"15","author":"Jacob","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2026.118133_b0230","doi-asserted-by":"crossref","unstructured":"Dong, C., J. Wu, Y. Chen, J. Nie, and C. Chen, Activation of PI3K\/AKT\/mTOR Pathway Causes Drug Resistance in Breast Cancer, Volume 12 - 2021 (2021).","DOI":"10.3389\/fphar.2021.628690"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226004685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226004685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T05:37:30Z","timestamp":1783921050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226004685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":46,"alternative-id":["S0006295226004685"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118133","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting CDK4 with repurposing perphenazine inhibited the growth of gastric cancer AGS and HGC27 cells by arresting cell cycle","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118133","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118133"}}